HU CFAR Grand Rounds video recordings

June 8, 2021
HU CFAR Grand Rounds : Cutting Edge Solutions in HIV Research

The Harvard University Center for AIDS Research virtual Grand Rounds series represents an opportunity for Harvard-affiliated HIV researchers and their collaborators to learn about and share high impact, cutting-edge research to the HU CFAR community. If you’re interested in presenting at a future webinar, suggest a topic, or learn more about it, please contact Mark Ingaciola at


Reflections on the Recent HIV Outbreak in Boston among People Who Inject Drugs
H. Dawn Fukuda, ScM (OHA in the Massachusetts Department of Public Health); Glory Ruiz, MD (Boston Medical Center); Sarah Mackin, MPH (Boston Public Health Commission)


Global Equity During Pandemics: Lessons from HIV and COVID for Designing a New Paradigm
An HGHI & HU CFAR Collaboration: Anthony S. Fauci, Director, National Institute of Allergy and Infectious Diseases (NIAID) & John Nkengasong, Director, Africa Centres for Disease Control and Prevention; Nominated Head of U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)
Watch on YouTube


Optimizing PrEP Adherence: What do we know, and what do we need to know?
Ft. Monica Gandhi, MD, MPH (UCSF); Peter Chai, MD (BWH); Christina Psaros, PhD (MGH); Conall O'Cleirigh, PdD (Fenway; MGH); Kenneth Mayer, MD (Fenway)


Anti-Racism Equity Lens is Needed in Ending the HIV Epidemic
Eliseo J. Pérez-Stable, MD, National Institute on Minority Health and Health Disparities (NIMHD)


COVID-19 vaccine hesitancy among Black immigrants in the U.S.
Adedotun Ogunbajo, PhD, 
Harvard T.H. Chan School of Public Health


Emerging science in US Adolescent HIV:Antibodies in acute HIV, long-acting injectables for prevention, study recruitment and retention
Jonathan Hill-Rorie, MPH, 
Fenway Community Health Center; Sybil Hosek, PhD, Cook County Health; Karin Nielsen, MD, Ronald Reagan UCLA Medical Center; UCLA Mattel Children's Hospital; UCLA Santa Monica Medical Center


Lancet Special Issue: HIV in the United States
Ada Adimora, MD, MPH (UNC); 
Chris Beyrer, MD (Hopkins); Patrick Sullivan, DVM, PhD (Emory); LaRon E. Nelson, PhD, RN, FNP, FNAP, FAAN (Yale); Sally Hodder, MD (U West Virginia); Jennifer Kates, PhD, MPA (Kaiser Family Foundation); Errol Fields, MD, MPH, PhD (Johns Hopkins); Carlos Rodrigues-Diaz, PhD, MPHE, MCHES (GW)


Forty Years of Solitude: Landmark Results from the S31/A5349 trial of Shortened Treatment for Drug-Susceptible Tuberculosis
Richard Chaisson, MD, 
Johns Hopkins University; Susan Dorman, MD, Medical University of South Carolina; Susan Swindells, MBBS, University of Nebraska Medical Center


Prevention of HIV and Other Emerging Infections: Things We Have Learned Over 40 Years
Myron S. Cohen, MD, University of North Carolina (UNC) at Chapel Hill


Antiretrovirals in Pregnancy: the VESTED and Tsepamo Study Results, and Participation of Pregnant Women in Clinical Research
Margaret Little, PhD, Kennedy Institute of Ethic, Georgetown University; Lameck Chinula MD, 
Global Women’s Health, UNC School of Medicine, Rebecca Zash, MD; Beth Israel Deaconess Medical Center; Shahin Lockman, MD, Brigham and Women's Hospital


"Long-acting Injectable Cabotegravir for HIV Pre-exposure Prophylaxis: What we know, What we don’t know, What we need to know for public health impact”
Raphael J. Landovitz, MD MSc, University of California